Amphastar Pharmaceuticals, Inc. (AMPH) stock
AMPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3013% below fair value
$29.71+0.61 (+2.10%)
Close on Nov 18, 2026Market cap $1.26BP/E 17.5Yield –
Amphastar Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Amphastar Pharmaceuticals's free cash flow for the twelve months ending Jun 30, 2026 was $152.89M, up 36.3% year over year. For fiscal 2025 it was $121.23M, down 29.7% from the year before. The highest annual figure on record is $172.35M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $121.23M | -29.7% |
| FY2024 | Dec 31, 2024 | $172.35M | +18.6% |
| FY2023 | Dec 31, 2023 | $145.34M | +123.1% |
| FY2022 | Dec 31, 2022 | $65.15M | -7.6% |
| FY2021 | Dec 31, 2021 | $70.54M | +201.3% |
| FY2020 | Dec 31, 2020 | $23.41M | +11209.7% |
| FY2019 | Dec 31, 2019 | $207.00K | – |
| FY2018 | Dec 31, 2018 | -$8.62M | -309.7% |
| FY2017 | Dec 31, 2017 | $4.11M | -76.1% |
| FY2016 | Dec 31, 2016 | $17.18M | – |
| FY2015 | Dec 31, 2015 | -$5.32M | -1061.1% |
| FY2014 | Dec 31, 2014 | $553.00K | -95.9% |
| FY2013 | Dec 31, 2013 | $13.40M | – |
| FY2012 | Dec 31, 2012 | -$24.78M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $42.73M | +70.7% |
| Q1 FY2026 | Mar 31, 2026 | $38.33M | +57.2% |
| Q4 FY2025 | Dec 31, 2025 | $24.59M | +48.0% |
| Q3 FY2025 | Sep 30, 2025 | $47.24M | +2.3% |
| Q2 FY2025 | Jun 30, 2025 | $25.03M | -60.3% |
| Q1 FY2025 | Mar 31, 2025 | $24.38M | -47.6% |
| Q4 FY2024 | Dec 31, 2024 | $16.61M | +15.2% |
| Q3 FY2024 | Sep 30, 2024 | $46.17M | -14.7% |
| Q2 FY2024 | Jun 30, 2024 | $63.07M | +37.5% |
| Q1 FY2024 | Mar 31, 2024 | $46.50M | +50.5% |
| Q4 FY2023 | Dec 31, 2023 | $14.42M | +61.8% |
| Q3 FY2023 | Sep 30, 2023 | $54.14M | +267.0% |
| Q2 FY2023 | Jun 30, 2023 | $45.87M | – |
| Q1 FY2023 | Mar 31, 2023 | $30.91M | -30.7% |
| Q4 FY2022 | Dec 31, 2022 | $8.92M | -73.4% |
| Q3 FY2022 | Sep 30, 2022 | $14.75M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.15M | -111.9% |
| Q1 FY2022 | Mar 31, 2022 | $44.63M | +193.5% |
| Q4 FY2021 | Dec 31, 2021 | $33.56M | +343.7% |
| Q3 FY2021 | Sep 30, 2021 | -$4.65M | -246.4% |
| Q2 FY2021 | Jun 30, 2021 | $26.42M | +37.6% |
| Q1 FY2021 | Mar 31, 2021 | $15.21M | – |
| Q4 FY2020 | Dec 31, 2020 | $7.56M | – |
| Q3 FY2020 | Sep 30, 2020 | $3.18M | – |
| Q2 FY2020 | Jun 30, 2020 | $19.20M | -54.3% |
| Q1 FY2020 | Mar 31, 2020 | -$6.53M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.76M | – |
| Q3 FY2019 | Sep 30, 2019 | -$20.68M | -757.4% |
| Q2 FY2019 | Jun 30, 2019 | $42.00M | – |
| Q1 FY2019 | Mar 31, 2019 | -$18.35M | – |
| Q4 FY2018 | Dec 31, 2018 | -$65.00K | – |
| Q3 FY2018 | Sep 30, 2018 | $3.15M | – |
| Q2 FY2018 | Jun 30, 2018 | -$7.72M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.98M | -126.3% |
| Q4 FY2017 | Dec 31, 2017 | -$353.00K | -104.1% |
| Q3 FY2017 | Sep 30, 2017 | -$8.94M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.73M | – |
| Q1 FY2017 | Mar 31, 2017 | $15.13M | – |
| Q4 FY2016 | Dec 31, 2016 | $8.67M | – |
| Q3 FY2016 | Sep 30, 2016 | -$5.40M | – |
See a number that looks wrong?